Patent regime and historic developments in India for the life sciences sector

By Arshad Jamil

India has a hard-won reputation as a major producer of generic pharmaceuticals. However, the IP framework around life sciences is evolving, prompting changes within the sector

Enter your details below to log into your account.

Subscribe for unlimited access to articles, in-depth analysis and research from the IAM experts.

Twitter

28 Oct 2020

@IAM_magazine As @TheLOTNET celebrates its 1000th member new analysis shows that the defensive operator now covers over 12% of gr… https://t.co/McK4O11C7o Read more

28 Oct 2020

@IAM_magazine BREAKING NEWS - The Ninth Circuit has denied an FTC request to have its antitrust case against Qualcomm - which the… https://t.co/iVALhc9w0U Read more

28 Oct 2020

@IAM_magazine RT @TheCIPA: Plenty of changes for IP at the end of the Transitional Period, but (and as the IPO notes) no change for patents. https://t.co… Read more

28 Oct 2020

@IAM_magazine Clarivate’s latest acquisition signals focus on growing base of data-hungry Chinese customers https://t.co/vGFfsbGTGU Read more

Find an expert

David J Teece

Chair

Emeryville, CA, United States

Berkeley Research Group, LLC

View full biography

Patent regime and historic developments in India for the life sciences sector

Returning user?

Want to read more?

TAGS

Twitter

Find an expert